To the Editor: Bajorek et al1 did not address two aspects of compliance that may be an issue in community care of patients with atrial fibrillation taking warfarin: time of dose, and point-of-care testing.
- Peter W Ford
- Angela Close
- Aged Care Panel, Adelaide North East Division of General Practice, Adelaide, SA.
Correspondence: pioneermed@adsl.on.net
Responses are now closed for this article.